IT ATC L01EX01 · updated 2 Nov 2026
Sunitinib shortage in Italy
Is there a Sunitinib shortage in Italy?
Yes. As of 2 Nov 2026, 11 Sunitinib products are reported short in Italy, the first since 31 Oct 2022. The company estimate for the return is 30 Nov 2026 (latest 31 Mar 2027). Main reason: increased demand.
Also short in Canada, France, Austria, Sweden. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SUNITINIB ZENTIVA discontinuation | ZENTIVA ITALIA S.R.L. | 31 Oct 2022 | not given | Increased demand Elevata richiesta |
| IT | SUNITINIB ZENTIVA discontinuation | ZENTIVA ITALIA S.R.L. | 1 Feb 2023 | not given | Increased demand Elevata richiesta |
| IT | SUNITINIB DR. REDDY'S | DR. REDDY'S S.R.L. | 28 Feb 2025 | not given | Increased demand Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero) |
| IT | SUNITINIB ZENTIVA discontinuation | ZENTIVA ITALIA S.R.L. | 30 Sep 2025 | not given | Manufacturing problem Problemi produttivi |
| IT | SUNITINIB TEVA | TEVA B.V. | 9 Mar 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | SUNITINIB MYLAN discontinuation | MYLAN S.P.A. | 25 Jun 2026 | not given | Increased demand Elevata richiesta |
| IT | SUTENT discontinuation | PFIZER EUROPE MA EEIG | 10 Jul 2026 | 30 Nov 2026 | Increased demand Elevata richiesta |
| IT | SUNITINIB TEVA discontinuation | TEVA B.V. | 4 Aug 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | SUNITINIB DR. REDDY'S discontinuation | DR. REDDY'S S.R.L. | 15 Oct 2026 | not given | Commercial decision or withdrawal Motivi commerciali: forniture discontinue |
| IT | SUNITINIB TEVA anticipated | TEVA B.V. | 23 Nov 2026 | 31 Mar 2027 | Manufacturing problem Problemi produttivi |
| IT | SUTENT anticipated | PFIZER EUROPE MA EEIG | 23 Nov 2026 | 7 Jan 2027 | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.